ArticleAdvances in therapy2021

Efficacy and Safety of Umeclidinium/Vilanterol in Current and Former Smokers with COPD: A Prespecified Analysis of The EMAX Trial.

Leif H Bjermer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.